News

Regeneron Pharmaceuticals has entered a new manufacturing and supply agreement with Fujifilm Diosynth Biotechnologies to broaden its capacity. Valued at more than $3bn, the partnership is set to ...
“Regeneron is an American success story, with over 80 percent of our workforce and assets in the U.S. and all of our FDA-approved medicines invented in our New York laboratories. Our innovative ...
Regeneron Pharmaceuticals has a 52-week low of $525.99 and a 52-week high of $1,211.20. The firm has a market capitalization of $65.57 billion, a PE ratio of 15.67, a price-to-earnings-growth ...
$3 billion FUJIFILM deal will nearly double Regeneron’s large-scale U.S. biologics manufacturing capacity over the next decade. Regeneron adds 7,000+ U.S. jobs in five years, with $7B+ in ...
April 22 (Reuters) - Regeneron Pharmaceuticals (REGN.O), opens new tab said on Tuesday it has signed a deal worth more than $3 billion with contract drug developer Fujifilm Diosynth, potentially ...
Regeneron Pharmaceuticals Inc. agreed to pay Fujifilm Diosynth Biotechnologies more than $3 billion over the next decade to help manufacture its medicines in the US, as the threat of tariffs looms ...
Sometimes, Karen Read might take things into her own hands, like when she got a "weak pour" at a bar the night her boyfriend died. Unhappy with the alcohol level, she added extra shots on her own ...
Jurors in the Karen Read murder case went on a field trip Friday — to the Massachusetts crime scene where she allegedly backed up into her cop boyfriend with her SUV and left him to die in the snow.
The second trial of Karen Read, a Massachusetts woman accused of killing her Boston officer boyfriend, wrapped up its fourth day of full testimony on April 25. Jurors visited the Canton ...
A firefighter who was among the first at the scene. A friend of the man found lying in the snow. And the man’s mother in tears recalling her son, a Boston police officer whose death is at the ...
Under a new 10-year agreement, Regeneron will pay CDMO powerhouse Fujifilm Diosynth Biotechnologies more than $3 billion to help manufacture bulk drug product for its commercial biologics in the ...